AmeriCann Adds Respected Greenhouse Scientist to
Cannabis Development Team
Dr. Brian Corr Named Director of Horticultural Science and
Operations
DENVER, CO / Accesswire / May 4, 2017 / AmeriCann, Inc.
(OTCQX: ACAN), an Agricultural Technology
company that is developing sustainable, state-of-the-art medical
cannabis cultivation properties, announced the hiring of Dr. Brian
Corr as Director of Horticultural Science and Operations.
Dr. Corr, a noted expert in controlled-environment horticulture,
is a 40-year veteran in the traditional horticulture industry with
companies such as Ball Horticulture and Syngenta (NYSE: SYT), which has a $43 billion market capitalization.
Dr. Corr will lead AmeriCanns management services division.
AmeriCann believes that for cannabis to reach its full potential
as a medicine it requires the best facilities and operations,
stated AmeriCann CEO Tim Keogh. Dr. Corr provides the best of
two worlds - the science of traditional horticulture with the
specific needs of cannabis cultivation.
Dr. Corr stated, AmeriCann and I share a vision for the
efficient and scientific production of the highest quality medical
marijuana possible to provide relief to patients. The
state-of-the-art facilities that we are developing are unique for
the cannabis industry and I am honored to take on this role with
the company.
AmeriCann is developing a 53-acre property in Massachusetts
(acquired from Boston Beer Company (SAM-NYSE) for $4,475,000 in
cash), as the Massachusetts Medical Cannabis Center (the MMCC). The
MMCC is approved for 1 million square feet and is expected to be
one of the largest and most technologically advanced cannabis
cultivation facilities in the nation. AmeriCann has plans to
replicate the MMCC design in regulated markets across the United
States.
About Dr. Brian Corr
With over forty years of experience in controlled-environment
horticulture, Dr. Corr is a well-known and sought after expert in
the scientific production of crops. Over his long career he has
traveled to over 30 countries to provide horticultural advice. He
will be Vice President of Operations for AmeriCann, responsible for
facility design, operations, and product development.
Dr. Corr has earned three degrees, including a PhD in plant
sciences. He has worked both in industry and academia. As a faculty
member at the University of Tennessee he specialized in
controlled-environment horticulture. He has also worked for
international firms specializing in plant genetics and crop
protection. Over the course of his career he has managed a research
greenhouse, had responsibility for international sales, was a
director of new crop development, managed the commercial
introduction of a product for certified-organic grape production,
and directed numerous research projects related to crop production,
including crop enhancement with beneficial microorganisms.
About AmeriCann
AmeriCann (OTCQX: ACAN) is a publicly traded Ag-Tech company that
is developing sustainable, state-of-the-art medical cannabis
cultivation properties. The Company has over 1,000,000 square feet
of facilities in the planning and design stages of development. The
Company has designed a proprietary line of cannabis infused
products which will be branded and licensed to companies in
regulated markets.
AmeriCann, Inc. is a Certified B
Corp, an acknowledgment of the companys commitment to social
and environmental ethics, transparency and accountability. AmeriCann became the first public
cannabis company to earn this respected accreditation. More
information about the Company is available at: www.americann.co or follow AmeriCann on Twitter @ACANinfo
About Massachusetts Medical Cannabis Center
The Massachusetts Medical Cannabis Center is approved for
nearly 1,000,000 square feet of medical cannabis
cultivation and processing in Freetown, Massachusetts. The
state-of-the-art, sustainable, greenhouse project will consist of
multiple planned phases for tenants in the Massachusetts medical
marijuana market. AmeriCanns Cannopy System uniquely combines
expertise from traditional horticulture, lean manufacturing,
regulatory compliance and cannabis cultivation to create superior
facilities and procedures.
The first phase of the project consists of 130,000 sq. ft. of
cultivation and processing infrastructure. AmeriCann can expand the
first phase to approximately 600,000 sq. ft., based on patient
demand.
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended (the Exchange Act) (which Sections were adopted as part of
the Private Securities Litigation Reform Act of 1995). Statements
preceded by, followed by or that otherwise include the words
believe, anticipate, estimate, expect, intend, plan, project,
prospects, outlook, and similar words or expressions, or future or
conditional verbs such as will, should, would, may, and could are
generally forward-looking in nature and not historical facts. These
forward-looking statements involve known and unknown risks,
uncertainties and other factors which may cause the Company's
actual results, performance or achievements to be materially
different from any anticipated results, performance or
achievements. The Company disclaims any intention to, and
undertakes no obligation to, revise any forward-looking statements,
whether as a result of new information, a future event, or
otherwise. For additional uncertainties that could impact the
Company's forward-looking statements, please see the Companys
Annual Report on Form 10-K for the year ended September 30, 2016,
which the Company has filed with the SEC and which may be viewed at
http://www.sec.gov.
Contact Information:
Corporate:
AmeriCann, Inc.
3200 Brighton Blvd. Unit 114
Denver, CO 80216
(303) 862-9000
info@americann.co
www.americann.co
@ACANinfo on Twitter
Investors:
Hayden IR
hart@haydenir.com
(917) 658-7878